SEC Form 4 · accession 0001209191-18-043812
Myovant Sciences Ltd. · MYOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Guinan
Director
Period of report
Jul 23, 2018
Accepted (ET)
Jul 24, 2018 · 7:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001679082
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $19.71 | Jul 23, 2018 | A | 45,000 | A | — | Jul 22, 2028 | Common Shares | 45,000 | 45,000 | D |
Explanation of responses
- F11/3rd of the shares underlying the option vest and become exercisable on July 23, 2019, with the balance of the shares vesting in eight equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the vesting date.